Zilganersen
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Zilganersen, covering 2026-03-23 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Zilganersen (ION373) in Patients With Alexander Disease (AxD) [Phase 3]